Vitamin H: Slow increase in terminal demand and overcapacity
Vitamin H is one of the B vitamins, also known as biotin, vitamin B7, coenzyme R (Coenzyme R), etc. It is an essential substance for the synthesis of vitamin C and an indispensable substance for metabolism. It is a nutrient necessary to maintain the human body's natural growth, development and normal human function and health. Vitamin H is currently mainly used in food and beverage, medicine, feed additives and other fields, of which feed additives account for a relatively high proportion of about 75%, followed by the pharmaceutical field accounting for about 18%, and the food and beverage field accounting for the lowest proportion at 7% about.
In recent years, under the background of stricter supervision on environmental protection and production safety, China’s vitamin production technology has been continuously improved, increasing production efficiency, expanding production, and reducing production costs. With a higher cost performance, it has become popular in overseas markets and exported. Higher.
The livestock and poultry breeding industry has developed for a long time, and the market growth rate has slowed down. Affected by factors such as African swine fever and the epidemic, the market demand for feed additives has increased. Therefore, the global vitamin H market demand is growing at a rate of about 5%. About 254 tons per year, of which more than 80% of the demand comes from overseas markets.
2026-09-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
Syngenta Caught in Trade Crossfire
-
India Prepares New Seed and Pesticide Laws
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Warning Letters Put GMP Back in Focus
-
FDA Tracks Industry Dye Removal
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
Recommend Reading
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
关于进一步规范化学品信息发布、加强全球管制目录宣导的公告 Announcement on Further Standardizing the Release of Chemical Information and Strengthening Public Awareness of Global Control Lists
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
In March, the Cost Pressure of Hydrofluoric Acid and Rigid Demand Compete, Market Prices Slightly Increase
-
Expected Minor Fluctuations in Lithium Carbonate Prices in October
-
Geopolitical Conflicts Reignite, Why Lithium Carbonate Has Not Shown the Same Frenzy as 4 Years Ago in China
-
Significant Supply Increase, Acrylonitrile Market Weak and Fluctuating
-
Geopolitical Premium Fades and Inventory Pressures Weigh on Oil Prices, Ending Five-Day Rally